1. Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial. Issue 1 (January 2021) Authors: Usmani, Saad Z; Hoering, Antje; Ailawadhi, Sikander; Sexton, Rachael; Lipe, Brea; Hita, Sandi Fredette; Valent, Jason; Rosenzweig, Michael; Zonder, Jeffrey A; Dhodapkar, Madhav; Callander, Natalie; Zimmerman, Todd; Voorhees, Peter M; Durie, Brian; Rajkumar, S Vincent; Richardson, Paul G; Orlowski... Journal: Lancet Issue: Volume 8:Issue 1(2021) Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 10 (October 2020) Authors: Kumar, Shaji K; Jacobus, Susanna J; Cohen, Adam D; Weiss, Matthias; Callander, Natalie; Singh, Avina K; Parker, Terri L; Menter, Alexander; Yang, Xuezhong; Parsons, Benjamin; Kumar, Pankaj; Kapoor, Prashant; Rosenberg, Aaron; Zonder, Jeffrey A; Faber, Edward; Lonial, Sagar; Anderson, Kenneth C; R... Journal: Lancet oncology Issue: Volume 21:Issue 10(2020) Page Start: 1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. Issue 2 (February 2023) Authors: Dytfeld, Dominik; Wróbel, Tomasz; Jamroziak, Krzysztof; Kubicki, Tadeusz; Robak, Paweł; Walter-Croneck, Adam; Czyż, Jarosław; Tyczyńska, Agata; Druzd-Sitek, Agnieszka; Giannopoulos, Krzysztof; Nowicki, Adam; Szczepaniak, Tomasz; Łojko-Dankowska, Anna; Matuszak, Magdalena; Gil, Lidia; Puła, Bartos... Journal: Lancet oncology Issue: Volume 24:Issue 2(2023) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma. (28th February 2019) Authors: Costello, Caitlin; Davies, Faith E; Cook, Gordon; Vela-Ojeda, Jorge; Omel, Jim; Rifkin, Robert M; Berdeja, Jesus; Puig, Noemi; Usmani, Saad Z; Weisel, Katja; Zonder, Jeffrey A; Terpos, Evangelos; Spencer, Andrew; Leleu, Xavier; Boccadoro, Mario; Thompson, Michael A; Romanus, Dorothy; Stull, Dawn ... Journal: Future oncology Issue: Volume 15:Number 13(2019) Page Start: 1411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗